医学
荟萃分析
拉丁美洲
哮喘
梅德林
环境卫生
免疫学
内科学
政治学
语言学
哲学
法学
作者
Armando Pareja Coronel,Nataly Mayely Sanchez-Tamay,Jhosmer Ballena-Caicedo,Fiorella Elvira Zuzunaga-Montoya,Luisa Erika Milagros Vásquez-Romero,Joan A. Loayza-Castro,Rafael Tapia‐Limonchi,Carmen Inés Gutierrez De Carrillo,Félix Llanos-Tejada,Víctor Juan Vera-Ponce
标识
DOI:10.1016/j.anai.2025.07.021
摘要
Background Asthma is a chronic respiratory disease that imposes a substantial health burden in Latin America. Objective To estimate the prevalence of asthma in adults across the region and evaluate the influence of methodological variables on its estimation. Methods A systematic review and meta-analysis followed PRISMA guidelines, with searches in PubMed, Scopus, Web of Science, and EMBASE. Cross-sectional studies reporting asthma prevalence using clinical diagnostic criteria, self-report, or pulmonary function tests were included. Data selection and extraction were performed independently by two reviewers, who also assessed the risk of bias. Meta-analysis was conducted using the metaprop function of the meta package in R, applying a random-effects model with the Hartung-Knapp approximation and the Freeman-Tukey proportion transformation. The I2 statistic was used to estimate heterogeneity, and meta-regressions were performed to explore the influence of publication year and diagnostic method on prevalence. Results Twenty-four studies with 176,205 participants were included. The combined overall prevalence of asthma was 6.84% (95% CI: 5.73–8.04), with high heterogeneity (I2>90%). Studies employing self-reported medical diagnosis and validated questionnaires tended to show higher estimates, while a single study based on spirometry reported the lowest prevalence (3.86%). Additionally, a higher prevalence was observed in women compared to men. Conclusion Asthma has a significant prevalence in Latin America's adult population, although its magnitude varies according to diagnostic and sampling methods. This landscape reflects cultural and epidemiological heterogeneity, demanding specific interventions to reduce the disease burden.
科研通智能强力驱动
Strongly Powered by AbleSci AI